In Kaluga at the site of the industrial park "Grabtsevo" the Danish company "Novo Nordisk" started construction of a pharmaceutical company for production of modern insulins.
Capacity of the plant is designed to ensure high-quality health care needs of Russians, patients with diabetes mellitus. In the first phase will be launched line of packing cartridges and injection pens. The total investment in the project is 100 million U.S. dollars. The enterprise will employ more than 240 people.
The new plant will be the seventh production of "Novo Nordisk" in the world and the first in Russia. Its commissioning is planned for 2014.